πŸ‡ΊπŸ‡Έ FDA
Patent

US 8992930

Extracellular IFI16 as therapeutic agents

granted A61KA61K2039/505A61P

Quick answer

US patent 8992930 (Extracellular IFI16 as therapeutic agents) held by University of Piemonte Orientale expires Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
University of Piemonte Orientale
Grant date
Tue Mar 31 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 26 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61K, A61K2039/505, A61P, A61P1/16, A61P17/00